483PA biomarker study to validate predictors for clinical outcome of cetuximab based chemotherapy in first-line metastatic colorectal cancer (mCRC) patients: JACCRO CC-05/06AR and FIRE-3. (23rd October 2018) - Sunakawa, Y; Stintzing, S; Cao, S; Luecke, J; Thompson, D; Moran, M; Astrow, S H; Hsiang, J; Stephens, C; Zhang, W; Tsuji, A; Takahashi, T; et al.